Eli Lilly Agrees Multi-Billion Dollar Deal to Acquire Mental Health Specialist
Amsterdam, Saturday 18 July 2026
Pharmaceutical giant Eli Lilly is acquiring AtaiBeckley for up to $3.8 billion, gaining access to pioneering psychedelic-based therapies designed to treat severe, treatment-resistant depression.